Login to Your Account

Clinic Roundup

Wednesday, July 20, 2011
Convergence Pharmaceuticals Ltd., of Cambridge, UK, started a Phase II study of CNV1014802 in treating pain associated with lumbasacral radiculopathy, a neuropathic pain condition caused by compression of the nerve roots in the lumbar region of the spine.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription